Ads
related to: biotechnology
Search results
Arthrosi Announces Multiple Presentations at the European League Against Rheumatism (EULAR) Congress...
KOLR - KSFX Ozarks· 13 hours agoArthrosi Therapeutics, Inc., a late-stage biotechnology company developing a potentially best-in-class, highly potent and selective next generation URAT1 inhibitor to reduce ...
Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI...
Benzinga· 3 hours agoREDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting
AXIM Biotechnologies Receives Medical Device Manufacturing License
Digital Journal· 2 days agoPRESS RELEASE Published May 29, 2024 NewMediaWire State of California Department of Public Heath Food and Drug Branch Issues the Company a License for Manufacturing of its Diagnostic Assays ...
Exploring Wuxi Chipown Micro-electronics And Two More Growth Leaders With High Insider Stakes On The...
Simply Wall St. via Yahoo Finance· 3 hours agoIn recent developments, Chinese markets have faced challenges with the Shanghai Composite and CSI...
A year ago, Takeda pledged to create local jobs in exchange for $1.8 million in tax breaks. Now,...
The Boston Globe· 5 hours agoTakeda, which had 6,290 workers in the state in 2023, according to the Massachusetts Biotechnology...
Q1 2024 Collplant Biotechnologies Ltd Earnings Call Transcript
Guru Focus· 1 day agoWelcome to the CollPlant Biotechnology investor conference call to discuss financial results for the first-quarter of 2024 and corporate updates. A brief question-and-answer ...
Turn Bio and HanAll to develop therapies for age-related conditions
Pharmaceutical Technology via Yahoo Finance· 2 days agoTurn Biotechnologies (Turn Bio) has entered an exclusive worldwide licensing agreement with HanAll...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 5 hours agoImmunocore is a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal ...
Lone Star College invests $500K into Montgomery campus' biotechnology program
Community Impact· 7 days agoThe Lone Star College-Montgomery Biotechnology Institute will be expanding its offerings and...
Evercore ISI cuts Editas Medicine stock target By Investing.com
Investing.com· 9 hours agoOn Thursday, Evercore ISI adjusted its outlook on Editas Medicine (NASDAQ:EDIT), a biotechnology...
